
USFDA APPLICATION NUMBER - 19219 / DOSAGE - SOLUTION/DROPS;OPHTHALMIC - 0.5%
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| levobunolol hydrochloride(UNII: O90S49LDHH) (levobunolol - UNII:G6317AOI7K) | levobunolol hydrochloride | 5mg in 1 | 2.5mg in 1 |
Inactive Ingredients
| Ingredient Name | Allergan, Inc. | Pacific Pharma, Inc. | Sandoz Inc |
|---|---|---|---|
| benzalkonium chloride(F5UM2KM3W7) | |||
| edetate disodium(7FLD91C86K) | |||
| hydrochloric acid(QTT17582CB) | |||
| POLYVINYL ALCOHOL(532B59J990) | |||
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |||
| POTASSIUM PHOSPHATE, MONOBASIC(4J9FJ0HL51) | |||
| sodium chloride(451W47IQ8X) | |||
| SODIUM HYDROXIDE(55X04QC32I) | |||
| sodium metabisulfite(4VON5FNS3C) | |||
| SODIUM PHOSPHATE, DIBASIC(GR686LBA74) | |||
| WATER(059QF0KO0R) |